Naitive Technologies Join Forces with Parvizi Surgical Innovation to Advance Osteoporosis Detection
Shots:
- Naitive Technologies has partnered with Parvizi Surgical Innovation (PSI) to advance OsteoSight, a technology for early detection of low bone mineral density
- The collaboration will leverage PSI's knowledge in R&D in musculoskeletal care to accelerate the application and clinical rollout of OsteoSight, improving access for patients with undiagnosed osteoporosis
- OsteoSight utilizes AI to scan routine X-rays for signs of low bone density for early diagnosis of osteoporosis. It was designated as a breakthrough device by the US FDA in 2023
Ref: PR Newswire | Image: Naitive & Parvizi Surgical Innovation
Related News:- Inocras and Summit Pharmaceuticals International Corporation Join Forces to Advance Healthcare in Japan
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
